Herman van Mellaert
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Herman van Mellaert
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
CropDesign NV
CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium.
8
| Subsidiary | Miscellaneous Commercial Services | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Herman van Mellaert tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
University of Bradford | College/University | Graduate Degree | |
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Private Equity Investor | |
deVGen NV
deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member | |
ABLYNX | Biotechnology | Director/Board Member | |
University of Leiden | College/University | Doctorate Degree Graduate Degree | |
Ghent University | College/University | Corporate Officer/Principal | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Chief Executive Officer Founder | |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Chairman Chairman | |
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Netherlands Genomics Initiative | Corporate Officer/Principal | ||
EMBL Enterprise Management Technology Transfer GmbH
EMBL Enterprise Management Technology Transfer GmbH Investment ManagersFinance Part of The European Molecular Biology Laboratory, EMBL Enterprise Management Technology Transfer GmbH is an alternative investment manager. The company is based in Heidelberg, Germany. The German company was founded in 1999. The CEO is Gabor M. Lamm. | Investment Managers | Chairman | |
The European Molecular Biology Laboratory | College/University | Chairman | |
Advanta-VanderHave Seeds | Corporate Officer/Principal | ||
Université Catholique de Louvain | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
INSERM Transfert Initiative SAS
INSERM Transfert Initiative SAS Investment ManagersFinance INSERM Transfert Initiative SAS is a venture capital fund that invests in companies located in France. It targets startups from the life sciences and biotechnology sectors, developing new medical practices with a strong intellectual property. It invests between €1 million and €3 million per company during mostly at pre-seed, seed and early-stages. | Investment Managers | Chairman | |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
Sequana Medical AG
Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Medical Specialties | Chairman | |
CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member | |
Curetis GmbH
Curetis GmbH Medical SpecialtiesHealth Technology Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany. | Medical Specialties | Director/Board Member | |
ABATTOIR N.V. | Food: Meat/Fish/Dairy | Director/Board Member | |
ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
Bio-Incubator Leuven
Bio-Incubator Leuven Real Estate DevelopmentFinance Bio-Incubator Leuven is a dynamic and innovative environment that provides lab space and support to R&D-intensive life sciences companies. The private company offers customizable modules that can be modified to meet the specific requirements of each client. The company is based in Leuven, Belgium. Leuven's knowledge institutes, including KU Leuven, University Hospitals Leuven, VIB, and IMEC, generate a huge outflow of knowledge that entails a myriad of innovative ideas for new and existing companies. The CEO of the Belgian company is Michaël de Blauwe. | Real Estate Development | Director/Board Member | |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Stichting De Weijerhorst
Stichting De Weijerhorst Investment Trusts/Mutual FundsMiscellaneous Stichting De Weijerhorst provides welfare and pension funds. The company is headquartered in Maastricht, the Netherlands. | Investment Trusts/Mutual Funds | Director/Board Member | |
BERGENBIO ASA | Pharmaceuticals: Major | Director/Board Member | |
BioActor BV
BioActor BV Chemicals: SpecialtyProcess Industries BioActor BV develops and markets health ingredients for dietary supplements and functional foods. Its products include BONOLIVE, CORDIART and NAXUS. The company was founded by Hans Van Der Saag in 2005 and is headquartered in Maastricht, the Netherlands. | Chemicals: Specialty | Chief Executive Officer | |
Q-Biologicals NV
Q-Biologicals NV BiotechnologyHealth Technology Q-Biologicals NV operates as a bio pharma contract development and manufacturing organization. It provides process development and bio manufacturing services to customers in the biopharmaceutical industry. The company was founded in 2011 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member | |
Lumeon Ltd.
Lumeon Ltd. Packaged SoftwareTechnology Services Lumeon Ltd. operates as a digital health company. It offers cloud-based management platform for outpatient care providers including doctors, ophthalmologists, and physiotherapists. The firm?s platform offers pre-operative and discharge readiness, chronic disease, post-acute care, lifestyle coaching, and imaging optimization solutions. The company was founded by Robbie M. Hughes on August 4, 2005 and is headquartered in London, the United Kingdom. | Packaged Software | Director/Board Member | |
Association of European Science & Technology Transfer | Founder | ||
Biolign NV | Director/Board Member | ||
AELIS FARMA | Biotechnology | Director/Board Member | |
Quadrille Capital SAS
Quadrille Capital SAS Investment ManagersFinance Quadrille Capital SAS (Quadrille Capital) is an independent private equity firm founded in 2007. The firm is headquartered in Paris, France with an additional office in United States. | Investment Managers | Private Equity Investor | |
CURETIS N.V. | Medical/Nursing Services | Director/Board Member | |
V-Bio Ventures BV
V-Bio Ventures BV Investment ManagersFinance V-Bio Ventures BV is an Independent Venture Capital firm founded in 2015 by Christina Takke and Willem Broekaert. V-Bio Ventures BV is headquartered in Ghent. | Investment Managers | Founder | |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
SEQUANA MEDICAL N.V. | Medical Specialties | Director/Board Member | |
Universite Paris Cite | College/University | Graduate Degree | |
Nobi NV
Nobi NV Medical/Nursing ServicesHealth Services Nobi NV operates as an elderly and residential care center. The company is based in Antwerp, Belgium. The Belgian company was founded by Roeland Pelgrims, Bert de Haes. Roeland Pelgrims has been the CEO since incorporation. | Medical/Nursing Services | Director/Board Member | |
V-Bio Management 1 BV
V-Bio Management 1 BV Financial ConglomeratesFinance Part of V-Bio Ventures BV, V-Bio Management 1 BV functions as an investment holding Belgian company. The company is based in Ghent, Belgium. | Financial Conglomerates | Director/Board Member | |
Lumeon, Inc. | Director/Board Member | ||
EQT Life Sciences Group BV
EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor | |
Health Economics Privak II NV
Health Economics Privak II NV Finance/Rental/LeasingFinance Health Economics Privak II NV is a Belgian company that provides credit intermediation services. The private company is based in De Pinte, Belgium. The company was founded in 2017. | Finance/Rental/Leasing | Director/Board Member | |
Opera Ballet Vlaanderen VZW
Opera Ballet Vlaanderen VZW Media ConglomeratesConsumer Services Opera Ballet Vlaanderen VZW is a performing arts company based in Antwerp, Belgium. The Belgian company engages in performing arts and related activities. The CEO of the non-profit company is Jan Raes. | Media Conglomerates | Director/Board Member | |
Axilum Robotics SAS
Axilum Robotics SAS Miscellaneous Commercial ServicesCommercial Services Axilum Robotics SAS develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures. Its first project is a robot to assist psychiatrists and neurologists for Transcranial Magnetic Stimulation (TMS). The firm's project TMS is a painless, non invasive medical technique that applies high intensity magnetic impulses to cortex areas by placing a coil on the surface of the head. The company was founded by Bernard Bayle, Michel Berg, Michel de Mathelin, Romuald Ginhoux, Benjamin Maurin and Pierre Renaud in April 2011 and is headquartered in Strasbourg, France. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
Belgio | 24 |
Paesi Bassi | 9 |
Francia | 8 |
Germania | 5 |
Regno Unito | 3 |
Settori
Health Technology | 17 |
Finance | 11 |
Consumer Services | 9 |
Commercial Services | 5 |
Health Services | 4 |
Posizioni
Director/Board Member | 62 |
Chairman | 14 |
Corporate Officer/Principal | 14 |
Independent Dir/Board Member | 6 |
Doctorate Degree | 6 |
Contatti più connessi
Insiders | |
---|---|
Rudy Dekeyser | 29 |
François Thomas | 25 |
Johan Cardoen | 19 |
Pol Bamelis | 14 |
Willem Broekaert | 7 |
Hans van der Saag | 7 |
Rindert Peerbolte | 3 |
Koen Bruynseels | 2 |
- Borsa valori
- Insiders
- Herman van Mellaert
- Connessioni Società